Form D · Biotechnology
COMPLETE GENOMICS INC
Mountain View, CA · CIK 0001361103
Offering snapshot reported Jul 2, 2009 · SEC filing
- Reported sold
- $14.5M Offering amount: $14.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2009 | Amendment | $14,490,061 | No comparison | 9 | SEC filing |
| Mar 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 5, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 19, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-89058
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| n/a | None |
Source: Form D, filed Jul 2, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alexander E. Barkas, Ph.D. | Director |
| Robert J. Curson | Executive |
| Clifford A. Reid | Director, Executive |
| Andrew Senyei, M.D. | Director |
| Charles P. Waite, Jr. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2071 Stierlin Court
Mountain View, CA, 94043
Mountain View, CA, 94043